Highlights from the ADVENT symposium at the 2023 World Congress of Dermatology in Singapore.
Atopic Dermatitis (AD) in Children: Early Intervention Can Reduce Long-Term Disease Impact
In the ADVENT symposium at the 2023 World Congress of Dermatology, entitled “Atopic Dermatitis in Children: Early Intervention Can Reduce Long-Term Disease Impact”, experts Amy Paller, MD (Northwestern University, USA), Mark Koh, MD (KK Women’s & Children’s Hospital, Singapore), Stephan Weidinger, MD, PhD (Christian-Albrecht University, Kiel, Germany), and Elaine Siegfried, MD (Saint Louis University School of Medicine, USA), delved into the challenges and advancements in the management of moderate-to-severe atopic dermatitis in pediatric patients. The presentations emphasized the significance of targeting type 2 inflammation, explored implications for disease course modification during childhood, and provided insights into emerging treatment options and practical management strategies for children with moderate-to-severe atopic dermatitis.
IL-4 and IL-13: Shared and Unique Roles in Atopic Dermatitis (AD) and Prurigo Nodularis (PN)
Atopic dermatitis and prurigo nodularis are dermatological conditions characterized by both common and distinct factors influencing their pathophysiology, presentation, and progression. In this ADVENT-sponsored symposium at the WCD 2023 Congress in Singapore, experts Mark Tang, MD (Mount Alvernia Hospital, Singapore), Lisa A. Beck, MD (University of Rochester, USA), and Gil Yosipovitch, MD (Miami Itch Center, USA), examined the shared and distinct clinical features between atopic dermatitis and prurigo nodularis.